Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti

Updated on: January 30,2024

Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti

Updated on:January 30,2024

New immunotherapy targeting tumor macrophages to tackle lung cancer

by Germans Trias i Pujol Research InstituteRImAb modifies the intratumoral myeloid cell compartment in a mouse model of LLC. a) Myeloid cell gating classification using the expression of surface marke

Updated on: February 18,2024

New immunotherapy targeting tumor macrophages to tackle lung cancer

by Germans Trias i Pujol Research InstituteRImAb modifies the intratumoral myeloid cell compartment in a mouse model of LLC. a) Myeloid cell gating classification using the expression of surface marke

Updated on:February 18,2024

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

by Elin Lindström,University of GothenburgCredit: Paul Björkman (Sahlgrenska Universitetssjukhuset)An algorithm can help health care professionals recognize which patients have a highly aggressi

Updated on: July 05,2024

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

by Elin Lindström,University of GothenburgCredit: Paul Björkman (Sahlgrenska Universitetssjukhuset)An algorithm can help health care professionals recognize which patients have a highly aggressi

Updated on:July 05,2024

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on: February 01,2024

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on:February 01,2024

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared

Updated on: April 20,2024

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared

Updated on:April 20,2024

Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy

by University of Miami Leonard M. Miller School of MedicineScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDRese

Updated on: February 20,2024

Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy

by University of Miami Leonard M. Miller School of MedicineScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDRese

Updated on:February 20,2024

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta

Updated on: April 06,2024

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta

Updated on:April 06,2024

Synthetic molecule proves able to mitigate heart failure in translational study

by Maria Fernanda Ziegler,FAPESPThe vicious cycle of heart failure (HF). (i) Impaired aldehyde metabolism by aldehyde dehydrogenase 2 (ALDH2); (ii) accumulation of 4-hydroxynonenal (4-HNE), a re

Updated on: April 01,2024

Synthetic molecule proves able to mitigate heart failure in translational study

by Maria Fernanda Ziegler,FAPESPThe vicious cycle of heart failure (HF). (i) Impaired aldehyde metabolism by aldehyde dehydrogenase 2 (ALDH2); (ii) accumulation of 4-hydroxynonenal (4-HNE), a re

Updated on:April 01,2024

Incoming New Zealand govt to abandon anti-smoking laws

Credit: CC0 Public DomainNew Zealand's incoming conservative government will jettison world-leading measures to stub out smoking, new Prime Minister Christopher Luxon confirmed Monday, in a move d

Updated on: March 06,2024

Incoming New Zealand govt to abandon anti-smoking laws

Credit: CC0 Public DomainNew Zealand's incoming conservative government will jettison world-leading measures to stub out smoking, new Prime Minister Christopher Luxon confirmed Monday, in a move d

Updated on:March 06,2024

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc

Updated on: January 30,2024

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc

Updated on:January 30,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on: March 06,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on:March 06,2024

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s

Updated on: March 01,2024

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s

Updated on:March 01,2024